SureTrader Advertisement PRTC
Home > Boards > US Listed > Medical - Drugs >

Arbutus Biopharma Corporation (ABUS)

Add ABUS Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board:
Last Post: 5/21/2016 11:10:40 PM - Followers: 103 - Board type: Free - Posts Today: 0

Arbutus Biopharma Corporation







Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201


As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.




Important Company Highlights: 

LNP Delivery Platform

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.





Recent News:





Links of importance for those that trade Canadian stocks:




 CNW Group Newswire:

Canadian Insider:

Currency Converter:


Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

Share Structure:   See filings

Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 Currency Converter:


 8-34-200/ 6 MOS ppo, accum.,R.S.I., PPS, vol 

daily retracement % 
18 mos, black, daily, retrace 3%, pos retrace 5%, retrace 7%, volume, candles, pps, 






 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ABUS News: Current Report Filing (8-k) 05/25/2016 02:09:50 PM
ABUS News: Quarterly Report (10-q) 05/04/2016 04:12:59 PM
ABUS News: Current Report Filing (8-k) 05/04/2016 04:05:36 PM
ABUS News: Arbutus Provides Corporate Update and Announces First Quarter 2016 Financial Results 05/04/2016 04:00:00 PM
ABUS News: Current Report Filing (8-k) 05/03/2016 04:57:27 PM
#4953  Sticky Note NEW COMPANY NAME/ ARBUTUS BIOPHARMA CORPORATION/ $ABUS recent news/filings[/b mick 08/06/15 01:42:07 PM
#5046   ABUS News: Quarterly Report (10-q) 05/04/2016 04:12:59 PM mick 05/21/16 11:10:40 PM
#5045   Arbutus Biopharma Co (ABUS) mick 05/21/16 11:10:27 PM
#5044   If the day comes and this trades above rivervalley 05/05/16 12:03:20 PM
#5043   and down it goes bernice 05/05/16 10:01:37 AM
#5042   No after hrs vol I can see so rivervalley 05/03/16 07:21:25 PM
#5041   Arbutus to Provide a Corporate Update and Release KarinCA 05/02/16 02:02:09 PM
#5040   ABUS News: Current Report Filing (8-k) 04/29/2016 08:02:15 AM mick 05/01/16 10:36:52 AM
#5039   Arbutus Biopharma Co (ABUS) mick 05/01/16 10:36:45 AM
#5038   Nanopatent On TV NECN, there is a piece on Echo20 04/29/16 12:22:27 AM
#5037,plamda mick 04/23/16 03:45:55 PM
#5036   Looking good so far today. Needs to pass rivervalley 04/22/16 12:42:36 PM
#5035   ABUS News: Current Report Filing (8-k) 04/14/2016 08:01:34 AM mick 04/18/16 01:23:33 PM
#5034   Arbutus Biopharma Co (ABUS) mick 04/18/16 01:23:27 PM
#5033   ABUS This seem more than a chart play, clydesur 04/08/16 10:33:11 AM
#5032   Another great day for ABUS. Keep them coming. rivervalley 04/07/16 11:50:31 PM
#5031   Nanopatent Maybe Dr. Murray will be successful. Echo20 Echo20 04/06/16 06:08:13 PM
#5030   Even the losers Note any selling pressures? Panama Papers? Echo20 Echo20 04/06/16 06:05:41 PM
#5029   No - I think it was a DUD! nanopatent 04/06/16 05:23:22 PM
#5028   Loser,,, S ? Really? eventhelosers 04/06/16 04:55:46 PM
#5027   Nanopatent Any luck on the flu with TKMR? Echo20 Echo20 04/06/16 04:43:58 PM
#5026   Chugging along so far today. Hope it blasts rivervalley 04/06/16 01:01:06 PM
#5025 mick 03/28/16 10:49:48 AM
#5024   With the latest buy this morning my average rivervalley 03/21/16 10:02:30 AM
#5023   It had an incredible run though before dropping rivervalley 03/18/16 09:03:11 PM
#5022   Tekmira was a flop with TKM-Ebola. nanopatent 03/18/16 07:40:00 PM
#5021   Nice end to the week. At some point rivervalley 03/18/16 06:16:23 PM
#5020   i really like 'Arbutus Biopharma Corporation (ABUS)' mick 03/09/16 02:49:12 PM
#5019   ABUS files 10-K aries4747 03/09/16 02:07:02 PM
#5018   ABUS News: Current Report Filing (8-k) 03/03/2016 06:20:37 PM mick 03/05/16 12:52:24 PM
#5017   Arbutus Biopharma Co (ABUS) mick 03/05/16 12:52:17 PM
#5016   Nice start here on a Friday, currently up rivervalley 03/04/16 12:15:43 PM
#5015   Looking good this morning. Long way to go rivervalley 03/02/16 12:02:46 PM
#5013   ABUS News: Arbutus Biopharma to Participate in Upcoming mick 02/07/16 09:55:14 AM
#5012   Arbutus Biopharma Co (ABUS) mick 02/07/16 09:55:08 AM
#5011   Who is working on a Zika vaccine? piecesofeight 02/01/16 11:03:08 AM
#5010   Just keeps dropping like it doesn't ever want rivervalley 01/28/16 01:55:17 PM
#5009   ABUS/ daily retracement % mick 01/20/16 02:52:59 PM
#5008,plamda mick 01/20/16 12:16:52 PM
#5007   DAILY/ mick 01/16/16 12:33:48 PM
#5006   Arbutus Biopharma Co (ABUS) mick 12/31/15 10:24:32 AM
#5005 mick 12/19/15 01:50:06 PM
#5004   while many others in this sector on my rivervalley 12/09/15 02:18:52 PM
#5003   made yet another buy of ABUS this afternoon. rivervalley 12/04/15 04:42:15 PM
#5002   Arbutus Biopharma Co (ABUS) mick 11/22/15 05:27:50 PM
#5001 mick 11/15/15 01:37:01 PM
#5000   Lets see if next week brings in the Tdash 11/13/15 01:59:00 PM
#4999 mick 11/07/15 01:29:11 PM
#4998   couldn't resist averaging down a little more this rivervalley 10/23/15 10:33:29 AM
#4997   Hard to believe this couldn't push through the rivervalley 10/22/15 01:43:01 PM
#4996 mick 10/20/15 08:02:40 AM